You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Roche
Pharmaceuticals
Sanofi
GSK
AstraZeneca
Novartis
AbbVie
Johnson and Johnson
Pfizer
Valneva
Novo Nordisk
Bristol Myers Squibb
Topics

Advertisement

Roche

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Safety concerns continue to plague Roche’s BTK inhibitor in RMS Clinical Trials Arena 1d

Clinical Trials Arena 1d

STAT Plus: With successful trials, Roche takes its MS drug to regulators, but safety questions loom STAT 3d

STAT 3d

Multiple Sclerosis Pharma

Drugs and Alcohol

Roche to launch global study of Elevidys following EU rejection Clinical Trials Arena 7d

Clinical Trials Arena 7d

Elevidys Duchenne

Advertisement

Advertisement

Roche confident despite strong Swiss franc, threat of generics ShareCast 1d

ShareCast 1d

Switzerland Pharma

Currency Markets

STAT Plus: Roche to launch another Elevidys trial, with eyes on European approval STAT 11:39 Thu, 16 Apr

STAT 11:39 Thu, 16 Apr

Roche builds Mrd testing arsenal in $595m Saga Diagnostics buyout Verdict Medical Devices 7d

Verdict Medical Devices 7d

Cancer Mergers and Acquisitions

Advertisement

Advertisement

Latest

In the last 2 hours

Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on Dme’ Campaign Business Wire (Press Release) 13:04

Yesterday

Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs BioPharma Dive 18:50 Thu, 23 Apr

RHHBY's Q1 Results Hit by Currency Headwinds, Sales Up 6% at CER Zacks 17:52 Thu, 23 Apr

Swiss tax revenues get bump from OECD minimum tax rate Swiss Info 12:41 Thu, 23 Apr

Roche confident despite strong Swiss franc, threat of generics ShareCast 12:05 Thu, 23 Apr

Swiss franc strength puts Roche's results in a poor light pharmaphorum 12:01 Thu, 23 Apr

Russia classifies Swiss organisation as ‘undesirable’ Swiss Info 11:54 Thu, 23 Apr

Safety concerns continue to plague Roche’s BTK inhibitor in RMS Clinical Trials Arena 08:57 Thu, 23 Apr

Wednesday

Roche Highlights Gazyva Progress, Reports Data on Enspryng, MS Drug Zacks 17:53 Wed, 22 Apr

STAT Plus: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy STAT 15:44 Wed, 22 Apr

Advertisement

Advertisement

Advertisement

Advertisement

Roche News

NewsNow brings you the latest news from the world’s most trusted sources on Roche pharmaceuticals, a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. NewsNow aims to be the world’s most accurate and comprehensive Roche news aggregator, bringing you the latest headlines automatically and continuously 24/7.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis